"Baseline test." The initial assessment through a urine drug
test to:
(1) identify the presence of an illegal substance prior
to prescribing a controlled substance; or
(2) confirm the presence or absence of a prescribed drug
or drug class.
"Controlled substance." A drug, substance or immediate
precursor included in Schedules II through V of section 4 of the
act of April 14, 1972 (P.L.233, No.64), known as The Controlled
Substance, Drug, Device and Cosmetic Act.
"Definitive drug test." A qualitative or quantitative ur ine
drug test used to identify specific drugs, specific drug
concentrations and associated metabolites.
"Department." The Department of Health of the Commonwealth.
"Individual." An individual who is at least 18 years of age.
"Medical emergency." A situation that, in the good faith
professional judgment of the prescriber, creates an immediate
threat of serious risk to the life or physical health of a
person.
"Opioid." Any of the following:
(1) A preparation or derivative of opium.
(2) A synthetic narcotic that has opiate-like effects
but is not derived from opium.
(3) A group of naturally occurring peptides that bind at
or otherwise influence opiate receptors, including an opioid
agonist.
"Periodic test." A random urine drug test that screens for a
random selection of drugs.
"Prescriber." As defined in the act of October 27, 2014
(P.L.2911, No.191), known as the Achieving Better Care by
20190SB0572PN0997 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30